FilingIndex
8-KThe WireRoutine

Shareholder Vote

Filed May 13, 2024 · 2y ago · Accession 0001437749-24-016208

Plain English

Material event — a significant development the company must disclose promptly.

Read the source below for the full document.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported): May 8, 2024     National Research Corporation (Exact name of registrant as specified in its charter)   Delaware 001-35929 47-0634000 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)   1245 Q Street , Lincoln , Nebraska 68508 (Address of principal executive offices) (Zip Code)   ( 402 ) 475-2525 (Registrant's telephone number, including area code)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)     ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)     ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))     ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class Trading Symbol(s) Name of each exchange on which registered $0.001 Par Value Common Stock NRC The NASDAQ Stock Market   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐         Item 5.07 Submission of Matters to a Vote of Security Holders.   On May 8, 2024, National Research Corporation, a Delaware corporation (the “Company”), held its 2024 annual meeting of shareholders (the “Annual Meeting”). At the Annual Meeting, the Company’s shareholders voted on the following proposals:     ● The election of two directors, Michael D. Hays and John N. Nunnelly, to the Board for a three-year term to expire at the Company’s 2027 annual meeting of shareholders;     ● The ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for 2024; and     ● An advisory vote to approve the compensation of the Company’s named executive officers as disclosed in the Company’s proxy statement relating to the Annual Meeting   As of the March 20, 2024, the record date for the determination of the shareholders entitled to notice of, and to vote at, the Annual Meeting, 23,871,543 shares of the Company’s common stock were outstanding and eligible to vote. Approximately 96% of all shares (and votes) were represented at the Annual Meeting or by proxy. The following are the final votes on the matters presented for shareholder consideration at the Annual Meeting:   Election of Directors   The shareholders elected Michael D. Hays and John N. Nunnelly as directors for three-year terms to expire at the Company’s 2027 annual meeting of shareholders. The results of the vote were as follows:       For   Against   Abstain   Broker Non-Votes Name   Votes   Percentage (1)   Votes   Percentage (1)   Votes   Percentage (2)   Votes   Percentage (2) Michael D. Hays   21,614,892   97.12%   640,441   2.87%   29,044   N/A   582,200   N/A John N. Nunnelly   20,297,568   91.20%   1,957,765   8.79%   29,044   N/A   582,200   N/A   Ratify Appointment of KPMG LLP for 2024   The shareholders ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for 2024. The results of the vote were as follows:   For   Against   Abstain   Broker Non-Votes Votes   Percentage (1)   Votes   Percentage (1)   Votes   Percentage (2)   Votes   Percentage (2) 22,668,033   99.18%   186,289   0.81%   12,255   N/A   0   N/A   Non-binding, Advisory Vote to Approve Executive Compensation   The shareholders approved on an advisory basis the compensation of the Company’s named executive officers as disclosed in the Company’s proxy statement relating to the Annual Meeting. The results of the non-binding, advisory vote were as follows:   For   Against   Abstain   Broker Non-Votes Votes   Percentage (1)   Votes   Percentage (1)   Votes   Percentage (2)   Votes   Percentage (2) 21,971,558   98.88%   248,724   1.11%   64,095   N/A   582,200   N/A   (1) Based on a total of all votes received and eligible to be counted as voted on this proposal at the Annual Meeting. (2) “N/A” means that abstentions and/or broker non-votes do not have any effect on the voting results on this proposal.         SIGNATURE   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.     NATIONAL RESEARCH CORPORATION   (Registrant)         Date: May 13, 2024 By: /s/ Linda Stacy     Linda Stacy     Secretary, Principal Financial Officer, and Principal Accounting Officer
Filing details
Company
NRC HEALTH
Ticker
NRC
CIK
70487
Form type
8-K
Filing date
May 13, 2024
Report date
May 8, 2024
Document
nrc20240510_8k.htm
Size
174 KB